Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management
Journal of Attention Disorders · 2025
DOI: 10.1177/10870547251378169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, 2025. Verfasst von Chris Folkins und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of New Brunswick, Fredericton, NB, Canada. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Students, Academic Performance. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study examines the impact of long-acting stimulant (LAS) pharmacotherapy for ADHD on academic outcomes among students in grades K-12 using retrospective analysis of administrative data.
Methods
ADHD diagnosis was identified based on ADHD management plans in school records, physician notes in billing records, and/or prescription records. Prescription records identified LAS-treated students ( n = 15,544), excluding those treated with immediate/intermediate-acting stimulants or atomoxetine. A control group without ADHD ( n = 204,681), and another with untreated ADHD ( n = 27,880) were also identified. The following outcomes were examined using multivariate regression: report card scores, standardized assessment exam performance, graduation from high school, school attendance, and transition to post-secondary education.
Results
ADHD was associated with lower average report card scores and provincial assessment exam scores and increased frequency of school absence among grades K-12, and decreased likelihood of high school graduation and transition to post-secondary education. LAS treatment was associated with improved report card (score estimate −4.93 Treated, −6.19 Untreated) and provincial assessment exam scores (percentile rank estimate −9.20 Treated, −11.50 Untreated) among grades 9 to 12, reduced absences among grades K-12 (absence rate estimate −3.33 Treated, 7.96 Untreated), and increased likelihood of graduation (OR of failure to graduate 1.39 Treated, 2.22 Untreated) and transition to post-secondary education (OR of no transition 0.77 Treated, 1.42 Untreated; reference = No ADHD group).
Conclusion
LAS pharmacotherapy is associated with improved academic performance, attendance, and likelihood of graduation and transition to post-secondary education.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of New Brunswick, Fredericton, NB, Canada.
- Takeda Pharmaceutical Company Limited, Toronto, ON, Canada.
ORCID-Profile: Chris Folkins
Zitieren
APA
Folkins, C., Somayaji, C., Gill, S. K., & Ted McDonald, J. (2025). Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management. Journal of Attention Disorders. https://doi.org/10.1177/10870547251378169
Vancouver
Folkins C, Somayaji C, Gill SK, Ted McDonald J. Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management. Journal of Attention Disorders. 2025. doi:10.1177/10870547251378169
BibTeX
@article{Folkins2025,
author = {Folkins, Chris and Somayaji, Chandy and Gill, Simerpal K and Ted McDonald, James},
title = {Academic Outcomes in Primary and Secondary School Students Prescribed Long-Acting Stimulants for ADHD Management},
journal = {Journal of Attention Disorders},
year = {2025},
doi = {10.1177/10870547251378169}
}
EUVIMED